TABLE 1.

Participant characteristics

Participant Number	Gender	Age (years)	Carcinoma Location	Lymphnode Involved	Endpoint	Berry Treatment Plasma (days)	Berry Treatment Biopsy (days)	Compliance (%)
1	Male	77	Rectal	No	Chemoradiation	5	17	98
2	Female	46	Rectal	No	Surgery	8	27	100
3	Male	55	Rectal	No	Surgery	7	19	98
4	Male	71	Ascending Colon	No	Surgery	12	16	100
5	Male	50	Rectal	No	Chemoradiation	15	15	100
6	Male	69	Ascending Colon	No	Surgery	13	27	98
7	Male	53	Rectal	No	Chemoradiation	26	27	96
8	Female	58	Rectal	Yes	Chemoradiation	19	20	73
9	Female	52	Rectal	No	Chemoradiation	5	20	62
10	Male	51	Rectal	No	Surgery	34	34	94
11	Male	55	Rectal	No	Chemoradiation	25	27	99
12	Male	41	Rectal	Yes	Chemoradiation	5	19	100
13	Male	57	Rectal	Yes	Chemoradiation	7	14	100
14	Male	65	Rectal	No	Chemoradiation	8	15	98
15	Male	72	Rectal	No	Chemoradiation	14	27	99
16	Male	82	Rectal	No	Chemoradiation	12	21	83
17	Male	55	Rectal	No	Chemoradiation	26	26	100
18	Female	66	Rectal	No	Chemoradiation	15	15	100
19	Male	37	Rectal	No	Chemoradiation	7	7	100
20	Male	72	Ascending Colon	No	Surgery	29	29	100
21	Male	49	Rectal	No	Chemoradiation	19	31	100
22	Female	47	Descending Colon	No	Unknown	63	63	100
23	Female	51	Rectal	No	Chemoradiation	11	11	100
24	Male	72	Rectal	No	Chemoradiation	15	15	96